Table 1. Clinical characteristics and Notch3 expression levels in patients with bladder cancer.
Variables | n | Notch3 expressiona | P-value | |
---|---|---|---|---|
Low (n = 19) | High (n = 40) | |||
Age (years) | ||||
< 50 | 2 | 1 | 1 | 0.544 |
≥ 50 | 57 | 18 | 39 | |
Gender | ||||
Female | 10 | 2 | 8 | 0.593 |
Male | 49 | 17 | 32 | |
Tumor stage | ||||
Ta | 1 | 1 | 0 | 0.584 |
Tis | 2 | 1 | 1 | |
T1 | 12 | 5 | 7 | |
T2 | 12 | 4 | 8 | |
T3 | 20 | 5 | 15 | |
T4 | 12 | 3 | 9 | |
Tumor size (cm3) | ||||
< 5 | 39 | 13 | 26 | 0.795 |
≥ 5 | 20 | 6 | 14 | |
Lymph node positivity | ||||
No | 45 | 15 | 30 | 0.996 |
Yes | 14 | 4 | 10 | |
Distant metastasis | ||||
M0 | 59 | 19 | 40 | --- |
Infiltration depth in bladder | ||||
Ta, T1, Tis | 15 | 6 | 9 | |
≥ T2 | 44 | 13 | 31 | |
Histological grade | ||||
PUNLMP | 8 | 4 | 4 | 0.291 |
Low | 28 | 10 | 18 | |
High | 23 | 5 | 18 |
aHigh = IRS of Notch3 expression > 4 points as assessed by immunohistochemistry; Low = IRS of Notch3 expression < 4 points (See Figure 2).
PUNLMP: papillary urothelial neoplasms of low malignant potential.